These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 34713838)

  • 1. Cause-specific mortality among patients with different molecular subtypes of T1-2N0M0 breast cancer: A population-based study.
    Wang D; Yi L; Zhang L; Wang Z
    Medicine (Baltimore); 2021 Oct; 100(43):e27605. PubMed ID: 34713838
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic factors and survival according to tumour subtype in women presenting with breast cancer bone metastases at initial diagnosis: a SEER-based study.
    Li X; Zhang X; Liu J; Shen Y
    BMC Cancer; 2020 Nov; 20(1):1102. PubMed ID: 33187507
    [TBL] [Abstract][Full Text] [Related]  

  • 3. All-Cause and Cardiovascular Disease Mortality Among Breast Cancer Survivors in CLUE II, a Long-Standing Community-Based Cohort.
    Ramin C; Schaeffer ML; Zheng Z; Connor AE; Hoffman-Bolton J; Lau B; Visvanathan K
    J Natl Cancer Inst; 2021 Feb; 113(2):137-145. PubMed ID: 32634223
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Race differences in cardiovascular disease and breast cancer mortality among US women diagnosed with invasive breast cancer.
    Troeschel AN; Liu Y; Collin LJ; Bradshaw PT; Ward KC; Gogineni K; McCullough LE
    Int J Epidemiol; 2019 Dec; 48(6):1897-1905. PubMed ID: 31155644
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pre- and Post-diagnosis Diabetes as a Risk Factor for All-Cause and Cancer-Specific Mortality in Breast, Prostate, and Colorectal Cancer Survivors: a Prospective Cohort Study.
    Tao H; O'Neil A; Choi Y; Wang W; Wang J; Wang Y; Jia Y; Chen X
    Front Endocrinol (Lausanne); 2020; 11():60. PubMed ID: 32132977
    [No Abstract]   [Full Text] [Related]  

  • 6. Cause-specific mortality after diagnosis of thyroid cancer: a large population-based study.
    Du B; Wang F; Wu L; Wang Z; Zhang D; Huang Z; Gao L; Li Y; Liang C; Li P; Yao R
    Endocrine; 2021 Apr; 72(1):179-189. PubMed ID: 32770440
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Racial Differences in 20-Year Cardiovascular Mortality Risk Among Childhood and Young Adult Cancer Survivors.
    Berkman AM; Brewster AM; Jones LW; Yu J; Lee JJ; Peng SA; Crocker A; Ater JL; Gilchrist SC
    J Adolesc Young Adult Oncol; 2017 Sep; 6(3):414-421. PubMed ID: 28530506
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk and prognostic factors of breast cancer with liver metastases.
    Ji L; Cheng L; Zhu X; Gao Y; Fan L; Wang Z
    BMC Cancer; 2021 Mar; 21(1):238. PubMed ID: 33676449
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Different patterns in the prognostic value of age for breast cancer-specific mortality depending on hormone receptor status: a SEER population-based analysis.
    Liu YR; Jiang YZ; Yu KD; Shao ZM
    Ann Surg Oncol; 2015 Apr; 22(4):1102-10. PubMed ID: 25249260
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A population-based study of cardiovascular disease mortality risk in US cancer patients.
    Sturgeon KM; Deng L; Bluethmann SM; Zhou S; Trifiletti DM; Jiang C; Kelly SP; Zaorsky NG
    Eur Heart J; 2019 Dec; 40(48):3889-3897. PubMed ID: 31761945
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Outcomes of patients with inflammatory breast cancer by hormone receptor- and HER2-defined molecular subtypes: A population-based study from the SEER program.
    Li J; Xia Y; Wu Q; Zhu S; Chen C; Yang W; Wei W; Sun S
    Oncotarget; 2017 Jul; 8(30):49370-49379. PubMed ID: 28472761
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mortality risk of black women and white women with invasive breast cancer by hormone receptors, HER2, and p53 status.
    Ma H; Lu Y; Malone KE; Marchbanks PA; Deapen DM; Spirtas R; Burkman RT; Strom BL; McDonald JA; Folger SG; Simon MS; Sullivan-Halley J; Press MF; Bernstein L
    BMC Cancer; 2013 May; 13():225. PubMed ID: 23642215
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Breast Cancer Mortality After a Diagnosis of Ductal Carcinoma In Situ.
    Narod SA; Iqbal J; Giannakeas V; Sopik V; Sun P
    JAMA Oncol; 2015 Oct; 1(7):888-96. PubMed ID: 26291673
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High cardiovascular disease mortality after endometrial cancer diagnosis: Results from the Surveillance, Epidemiology, and End Results (SEER) Database.
    Felix AS; Bower JK; Pfeiffer RM; Raman SV; Cohn DE; Sherman ME
    Int J Cancer; 2017 Feb; 140(3):555-564. PubMed ID: 27741565
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Older Patients With Early-stage Breast Cancer: Adjuvant Radiation Therapy and Predictive Factors for Cancer-related Death.
    Nagar H; Yan W; Christos P; Chao KSC; Nori D; Ravi A
    Am J Clin Oncol; 2017 Jun; 40(3):300-305. PubMed ID: 25333731
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The prognosis analysis of different metastasis pattern in patients with different breast cancer subtypes: a SEER based study.
    Wang H; Zhang C; Zhang J; Kong L; Zhu H; Yu J
    Oncotarget; 2017 Apr; 8(16):26368-26379. PubMed ID: 28038448
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic significance of young age (<35 years) by subtype based on ER, PR, and HER2 status in breast cancer: a nationwide registry-based study.
    Kim EK; Noh WC; Han W; Noh DY
    World J Surg; 2011 Jun; 35(6):1244-53. PubMed ID: 21472372
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased risk of breast cancer-specific mortality among cancer survivors who developed breast cancer as a second malignancy.
    Wang C; Hu K; Deng L; He W; Fang F; Tamimi RM; Lu D
    BMC Cancer; 2021 May; 21(1):491. PubMed ID: 33941118
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of survival in non-metastatic inflammatory and other T4 breast cancers: a SEER population-based analysis.
    Jiao D; Zhang J; Zhu J; Guo X; Yang Y; Xiao H; Liu Z
    BMC Cancer; 2021 Feb; 21(1):138. PubMed ID: 33549037
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Racial differences in outcomes for patients with metastatic breast cancer by disease subtype.
    Vaz-Luis I; Lin NU; Keating NL; Barry WT; Lii H; Winer EP; Freedman RA
    Breast Cancer Res Treat; 2015 Jun; 151(3):697-707. PubMed ID: 26022349
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.